[시장보고서]혈역학적 모니터링 기기 시장 규모, 점유율 및 동향 분석 보고서 : 시스템 유형별, 제품별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

혈역학적 모니터링 기기 시장 규모, 점유율 및 동향 분석 보고서 : 시스템 유형별, 제품별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Hemodynamic Monitoring Devices Market Size, Share & Trends Analysis Report By System Type (Invasive, Minimally Invasive, Non-Invasive), By Product (Disposables, Monitors), By End Use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1869864

리서치사 : Grand View Research

발행일 : 2025년 10월

페이지 정보 : 영문 190 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,620,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,069,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,967,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

혈역학적 모니터링 기기 시장 요약

세계의 혈역학적 모니터링 기기 시장 규모는 2024년 15억 8,000만 달러로 평가되었고, 2033년까지 27억 8,000만 달러에 이를 것으로 예측됩니다.

2025-2033년의 CAGR은 6.5%를 나타낼 전망입니다. 이러한 성장은 심혈관 질환 및 중증 질환의 유병률 증가, 인공지능(AI) 및 예측 분석 기술의 통합, 최소 침습적 및 비침습적 모니터링 기법에 대한 수요 증가, 실시간 데이터 및 무선 연결성을 포함한 모니터링 기기의 기술 발전 등 여러 주요 요인에 의해 주도되고 있습니다.

심혈관 질환(CVD) 및 관련 위험 요인의 증가 추세는 혈역학적 모니터링 기기 수요를 촉진할 것으로 예상됩니다. 혈역학적 모니터링 기기는 심부전 위험 평가 및 감소에 점점 더 중요한 역할을 수행합니다. 이식형 장치와 같은 혈역학적 모니터링 기기는 폐동맥압과 같은 요소에 대한 객관적 데이터를 제공합니다. 이를 통해 의사는 심부전으로 인한 입원 또는 사망 위험이 높은 환자를 식별할 수 있습니다. 심부전은 전 세계적으로 주요 사망 원인 중 하나입니다. 예를 들어, 미국 질병통제예방센터(CDC)에 따르면 미국 내 20세 이상 성인 약 670만 명이 심부전을 앓고 있습니다.

또한, 심장 돌연사(SCA)의 증가로 인해 혈역학적 모니터링 기기 산업의 수요는 지속적으로 증가하고 있습니다. 심정지는 일반적으로 중증 또는 치명적이며, 여러 국가에서 생존율이 낮은 편인데, 특히 병원 밖에서 발생한 경우 더욱 그렇습니다.미국 심장협회(AHA)의 '2022년 심장 및 뇌졸중 통계'에 따르면 미국에서는 연간 35만 6,000건 이상의 원외 심정지가 발생하여 그 약 90%가 사망에 이르고 있습니다. 따라서 심정지 발생률 증가로 인해 심박조율기 수요가 증가할 것으로 예상됩니다.

노화 과정은 심혈관계에 상당한 변화를 일으키므로, 고령 중환자실 환자에게는 신중한 혈역학적 관리가 필수적입니다. 노화가 진행됨에 따라 자율신경계의 균형이 점차 변화합니다. 휴식 시 부교감 신경 활동은 약화되고 교감 신경 활동은 증가합니다. 이러한 불균형은 노인에서 심혈관 합병증 위험을 높입니다.

동시에 전 세계 인구는 급속히 고령화되고 있습니다. WHO에 따르면, 60세 이상 인구는 2020년 약 10억 명에서 2030년 14억 명으로 증가할 것으로 예상되며, 2050년에는 약 21억 명에 이를 전망입니다. 결과적으로 최근 몇 년간 중증 질환을 경험하는 노인 환자 수가 크게 증가하여, 이 취약 계층에서 첨단 혈역학적 모니터링의 필요성이 부각되고 있습니다.

지역별 시장 대시보드
지역 시장 : 주요 포인트
북미
- 미국
- 주요국의 동향
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제8장 경쟁 구도

참가자 개요
기업의 시장 점유율/위치 분석(2024년, %)
기업 분류
전략 매핑
기업 프로파일/상장 기업
- BD
- GE HealthCare
- Baxter
- ICU Medical, Inc.
- Koninklijke Philips NV
- Masimo Corporation
- Deltex Medical Limited
- Getinge
- Nihon Kohden Corporation
- OSYPKA MEDICAL
- Schwarzer Cardiotek GmbH
- Caretaker Medical
- Medtronic
- Retia Medical Systems, Inc.
- Sramek BioDynamics, Inc.

HBR

영문 목차

영문목차

Hemodynamic Monitoring Devices Market Summary

The global hemodynamic monitoring devices market size was estimated at USD 1.58 billion in 2024 and is projected to reach USD 2.78 billion by 2033, growing at a CAGR of 6.5% from 2025 to 2033. The growth is driven by several key factors, such as the rising prevalence of cardiovascular diseases and critical illnesses, integration of AI and predictive analytics, growing demand for minimally invasive and non-invasive monitoring techniques, and technological advancements in monitoring devices, including real-time data and wireless connectivity.

The increasing prevalence of CVDs and associated risk factors is anticipated to boost the demand for hemodynamic monitoring devices. Hemodynamic monitoring devices play an increasingly important role in assessing and reducing the risk of heart failure. Hemodynamic monitoring devices, such as implantable devices, provide objective data on factors like pulmonary artery pressure. This allows doctors to identify patients at higher risk for hospitalization or even death from heart failure. Heart failure is one of the leading causes of death across the globe; for instance, according to the CDC, around 6.7 million adults of 20 years and older in the U.S. have heart failure.

In addition, the demand in the hemodynamic monitoring devices industry is constantly growing due to the rising prevalence of Sudden Cardiac Arrests (SCA). Cardiac arrests are generally severe or fatal, and the survival rate in several countries is low, mainly in cases of out-of-hospital attacks. According to the Heart and Stroke Statistics 2022 by the American Heart Association, more than 356,000 out-of-hospital cardiac arrests occur in the U.S. every year, with around 90% of them resulting in death. Hence, the increasing prevalence of cardiac arrest is anticipated to boost the demand for pacemakers.

The aging process significantly changes the cardiovascular system, making careful hemodynamic management essential for older ICU patients. As people age, the balance of the autonomic nervous system gradually shifts: parasympathetic activity weakens while resting sympathetic activity increases. This imbalance heightens the risk of cardiovascular complications in elderly individuals.

At the same time, the global population is aging rapidly. According to the WHO, the number of people aged 60 and above is projected to rise from around 1 billion in 2020 to 1.4 billion by 2030, reaching approximately 2.1 billion by 2050. Consequently, the number of elderly patients experiencing critical illnesses has grown substantially in recent years, underscoring the increasing need for advanced hemodynamic monitoring in this vulnerable population.

Global Hemodynamic Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hemodynamic monitoring devices market report based on system type, product, end use, and region:

System Type Outlook (Revenue, USD Million, 2021 - 2033)
Invasive
Minimally Invasive
Non-Invasive
Product Outlook (Revenue, USD Million, 2021 - 2033)
Disposables
Monitors
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Catheterization Labs
Other
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. System Type
- 1.2.2. Product
- 1.2.3. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Rising prevalence of cardiovascular diseases and critical illnesses.
  - 3.2.1.2. Growing demand for minimally invasive and non-invasive monitoring techniques.
  - 3.2.1.3. Technological advancements in monitoring devices, including real-time data and wireless connectivity.
  - 3.2.1.4. Adoption of remote patient monitoring and tele-ICU solutions.
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High cost of advanced hemodynamic monitoring systems
  - 3.2.2.2. Risk of complications with invasive monitoring methods
- 3.2.3. Industry Opportunity Analysis
- 3.2.4. Industry Challenge Analysis
3.3. Business Environment Analysis
- 3.3.1. Porter's Five Forces Analysis
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Economic and Social landscape
  - 3.3.2.3. Technological landscape
  - 3.3.2.4. Environmental landscape
  - 3.3.2.5. Legal Landscape

Chapter 4. Hemodynamic Monitoring Devices Market: System Type Estimates & Trend Analysis

4.1. System Type Segment Dashboard
4.2. System Type Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by System Type, 2021 to 2033 (USD Million)
4.4. Invasive
- 4.4.1. Market estimates and forecast 2021 to 2033, (USD Million)
4.5. Minimally Invasive
- 4.5.1. Market estimates and forecast 2021 to 2033, (USD Million)
4.6. Non-Invasive
- 4.6.1. Market estimates and forecast 2021 to 2033, (USD Million)

Chapter 5. Hemodynamic Monitoring Devices Market: Products Estimates & Trend Analysis

5.1. Products Segment Dashboard
5.2. Products Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by Products, 2021 to 2033 (USD Million)
5.4. Disposables
- 5.4.1. Market estimates and forecast 2021 to 2033, (USD Million)
5.5. Monitors
- 5.5.1. Market estimates and forecast 2021 to 2033, (USD Million)

Chapter 6. Hemodynamic Monitoring Devices Market: End Use Estimates & Trend Analysis

6.1. End Use Segment Dashboard
6.2. End Use Market Share Movement Analysis, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Hospitals
- 6.4.1. Market estimates and forecast 2021 to 2033, (USD Million)
6.5. Catheterization Labs
- 6.5.1. Market estimates and forecast 2021 to 2033, (USD Million)
6.6. Others
- 6.6.1. Market estimates and forecast 2021 to 2033, (USD Million)

Chapter 7. Hemodynamic Monitoring Devices Market: Regional Estimates & Trend Analysis

7.1. Regional Market Dashboard
7.2. Regional Market: Key Takeaways
7.3. North America
- 7.3.1. North America Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.3. Key country dynamics
  - 7.3.3.1. Regulatory framework/Reimbursement Scenario
  - 7.3.3.2. Competitive insights
  - 7.3.3.3. U.S. Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Canada
  - 7.3.4.1. Key country dynamics
  - 7.3.4.2. Regulatory framework/Reimbursement Scenario
  - 7.3.4.3. Competitive insights
  - 7.3.4.4. Canada Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.5. Mexico
  - 7.3.5.1. Key country dynamics
  - 7.3.5.2. Regulatory framework/Reimbursement Scenario
  - 7.3.5.3. Competitive insights
  - 7.3.5.4. Mexico Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
7.4. Europe
- 7.4.1. Europe Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework/Reimbursement Scenario
  - 7.4.2.3. Competitive insights
  - 7.4.2.4. Germany Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.3. UK
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework/Reimbursement Scenario
  - 7.4.3.3. Competitive insights
  - 7.4.3.4. UK Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Regulatory framework/Reimbursement Scenario
  - 7.4.4.3. Competitive insights
  - 7.4.4.4. France Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
  - 7.4.5.1. Key country dynamics
  - 7.4.5.2. Regulatory framework/Reimbursement Scenario
  - 7.4.5.3. Competitive insights
  - 7.4.5.4. Italy Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
  - 7.4.6.1. Key country dynamics
  - 7.4.6.2. Regulatory framework/Reimbursement Scenario
  - 7.4.6.3. Competitive insights
  - 7.4.6.4. Spain Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
  - 7.4.7.1. Key country dynamics
  - 7.4.7.2. Regulatory framework/Reimbursement Scenario
  - 7.4.7.3. Competitive insights
  - 7.4.7.4. Denmark Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
  - 7.4.8.1. Key country dynamics
  - 7.4.8.2. Regulatory framework/Reimbursement Scenario
  - 7.4.8.3. Competitive insights
  - 7.4.8.4. Sweden Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
  - 7.4.9.1. Key country dynamics
  - 7.4.9.2. Regulatory framework/Reimbursement Scenario
  - 7.4.9.3. Competitive insights
  - 7.4.9.4. Norway Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
7.5. Asia Pacific
- 7.5.1. Asia Pacific Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Japan
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/Reimbursement Scenario
  - 7.5.2.3. Competitive insights
  - 7.5.2.4. Japan Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.3. China
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework/Reimbursement Scenario
  - 7.5.3.3. Competitive insights
  - 7.5.3.4. China Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework/Reimbursement Scenario
  - 7.5.4.3. Competitive insights
  - 7.5.4.4. India Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.5. South Korea
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework/Reimbursement Scenario
  - 7.5.5.3. Competitive insights
  - 7.5.5.4. South Korea Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Australia
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework/Reimbursement Scenario
  - 7.5.6.3. Competitive insights
  - 7.5.6.4. Australia Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Thailand
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Regulatory framework/Reimbursement Scenario
  - 7.5.7.3. Competitive insights
  - 7.5.7.4. Thailand Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
7.6. Latin America
- 7.6.1. Latin America Hemodynamic Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/Reimbursement Scenario
  - 7.6.2.3. Competitive insights
  - 7.6.2.4. Brazil Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework/Reimbursement Scenario
  - 7.6.3.3. Competitive insights
  - 7.6.3.4. Argentina Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
7.7. MEA
- 7.7.1. MEA Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/Reimbursement Scenario
  - 7.7.2.3. Competitive insights
  - 7.7.2.4. South Africa Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework/Reimbursement Scenario
  - 7.7.3.3. Competitive insights
  - 7.7.3.4. Saudi Arabia Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework/Reimbursement Scenario
  - 7.7.4.3. Competitive insights
  - 7.7.4.4. UAE Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
  - 7.7.5.1. Key country dynamics
  - 7.7.5.2. Regulatory framework/Reimbursement Scenario
  - 7.7.5.3. Competitive insights
  - 7.7.5.4. Kuwait Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Share/Position Analysis, 2024 (%)
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. BD
  - 8.5.1.1. Overview
  - 8.5.1.2. Financial performance
  - 8.5.1.3. Product benchmarking
  - 8.5.1.4. Strategic initiatives
- 8.5.2. GE HealthCare
  - 8.5.2.1. Overview
  - 8.5.2.2. Financial performance
  - 8.5.2.3. Product benchmarking
  - 8.5.2.4. Strategic initiatives
- 8.5.3. Baxter
  - 8.5.3.1. Overview
  - 8.5.3.2. Financial performance
  - 8.5.3.3. Product benchmarking
  - 8.5.3.4. Strategic initiatives
- 8.5.4. ICU Medical, Inc.
  - 8.5.4.1. Overview
  - 8.5.4.2. Financial performance
  - 8.5.4.3. Product benchmarking
  - 8.5.4.4. Strategic initiatives
- 8.5.5. Koninklijke Philips N.V.
  - 8.5.5.1. Overview
  - 8.5.5.2. Financial performance
  - 8.5.5.3. Product benchmarking
  - 8.5.5.4. Strategic initiatives
- 8.5.6. Masimo Corporation
  - 8.5.6.1. Overview
  - 8.5.6.2. Financial performance
  - 8.5.6.3. Product benchmarking
  - 8.5.6.4. Strategic initiatives
- 8.5.7. Deltex Medical Limited
  - 8.5.7.1. Overview
  - 8.5.7.2. Financial performance
  - 8.5.7.3. Product benchmarking
  - 8.5.7.4. Strategic initiatives
- 8.5.8. Getinge
  - 8.5.8.1. Overview
  - 8.5.8.2. Financial performance
  - 8.5.8.3. Product benchmarking
  - 8.5.8.4. Strategic initiatives
- 8.5.9. Nihon Kohden Corporation
  - 8.5.9.1. Overview
  - 8.5.9.2. Financial performance
  - 8.5.9.3. Product benchmarking
  - 8.5.9.4. Strategic initiatives
- 8.5.10. OSYPKA MEDICAL
  - 8.5.10.1. Overview
  - 8.5.10.2. Financial performance
  - 8.5.10.3. Product benchmarking
  - 8.5.10.4. Strategic initiatives
- 8.5.11. Schwarzer Cardiotek GmbH
  - 8.5.11.1. Overview
  - 8.5.11.2. Financial performance
  - 8.5.11.3. Product benchmarking
  - 8.5.11.4. Strategic initiatives
- 8.5.12. Caretaker Medical
  - 8.5.12.1. Overview
  - 8.5.12.2. Financial performance
  - 8.5.12.3. Product benchmarking
  - 8.5.12.4. Strategic initiatives
- 8.5.13. Medtronic
  - 8.5.13.1. Overview
  - 8.5.13.2. Financial performance
  - 8.5.13.3. Product benchmarking
  - 8.5.13.4. Strategic initiatives
- 8.5.14. Retia Medical Systems, Inc.
  - 8.5.14.1. Overview
  - 8.5.14.2. Financial performance
  - 8.5.14.3. Product benchmarking
  - 8.5.14.4. Strategic initiatives
- 8.5.15. Sramek BioDynamics, Inc.
  - 8.5.15.1. Overview
  - 8.5.15.2. Financial performance
  - 8.5.15.3. Product benchmarking
  - 8.5.15.4. Strategic initiatives

한글목차

혈역학적 모니터링 기기 시장 요약

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장의 변수, 동향, 범위

제4장 혈역학적 모니터링 기기 시장 : 시스템 유형별 추정 및 동향 분석

제5장 혈역학적 모니터링 기기 시장 : 제품별 추정 및 동향 분석

제6장 혈역학적 모니터링 기기 시장 : 최종 용도별 추정 및 동향 분석

제7장 혈역학적 모니터링 기기 시장 : 지역별 추정 및 동향 분석